High Alert
Spectrum:
Absorption: IV administration results in complete bioavailability.
Distribution: Extensively distributed to body tissues and fluids. Poor penetration into CSF.
Half-Life: Biphasicinitial phase, 2448 hr; terminal phase, 15 days. Lipid complex: 174 hr. Liposomal: 100153 hr.
Contraindicated in:
Use Cautiously in:
CV: chest pain, hypotension, edema, hypertension, tachycardia
Derm: pruritus, rashes
F and E: hyperglycemia, hypocalcemia, hypokalemia, hypomagnesemia
GI: ↑liver enzymes, diarrhea, hyperbilirubinemia, nausea, vomiting, abdominal pain
GU: nephrotoxicity, hematuria
Hemat: anemia, leukopenia, thrombocytopenia
Local: phlebitis
MS: arthralgia, myalgia
Neuro: anxiety, confusion, headache, insomnia
Resp: dyspnea, hypoxia, wheezing
Misc: chills, fever, acute infusion reactions, HYPERSENSITIVITY REACTIONS
Drug-drug:
Amphotericin Deoxycholate
Amphotericin B Lipid Complex (Abelcet)
Amphotericin B Liposome (AmBisome)
Amphotericin Deoxycholate
Amphotericin B Lipid Complex
Amphotericin B Liposome
Lab Test Considerations:
Amphotericin B Deoxycholate
IV Administration:
Amphotericin B Lipid Complex
IV Administration:
Amphotericin B Liposome
IV Administration:
NDC Code